Research and Markets: Leukemia - Pipeline Review, 2015

Research and Markets (http://www.researchandmarkets.com/research/vz5c44/leukemia) has announced the addition of the "Leukemia - Pipeline Review, 2015" report to their offering.

This Medical Devices sector report, Leukemia - Pipeline Review, 2015" provides an overview of Leukemia diagnostic tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Leukemia diagnostic tests pipeline products.

Key Topics Covered:

  • Extensive coverage of the Leukemia diagnostic tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Leukemia diagnostic tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Benefits of this Report:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Leukemia diagnostic tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Companies Mentioned Include:

  • Abbott Diagnostics
  • BioSense Technologies, Inc.
  • Cancer Genetics, Inc.
  • Di.V.A.L Toscana srl
  • IV Diagnostics, Inc.
  • Jaden BioScience Inc.
  • MolecularMD, Corp.
  • OncoVista Innovative Therapies, Inc.
  • Qiagen N.V.
  • Siemens Healthcare Diagnostics Inc.
  • Skyline Diagnostics BV
  • St. Jude Children's Research Hospital, Inc.
  • The Feinstein Institute for Medical Research
  • University of Barcelona
  • Vela Diagnostics
  • Wake Forest Baptist Medical Center
  • Xiamen Zeesan Biotech Co.,Ltd

Report Structure:

1.1 List of Tables

1.2 List of Figures

2 Introduction

3 Products under Development

4 Leukemia - Pipeline Products under Development by Companies

5 Leukemia Companies and Product Overview

6 Leukemia- Recent Developments

7 Appendix

For more information visit http://www.researchandmarkets.com/research/vz5c44/leukemia

Contacts:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Leukemia, In Vitro Diagnostics

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.